←Back to Expert Scholars
Translational Medicine / 转化医学Zanubrutinib and CLL
Constantine Tam
MBBS, MD
🏢Alfred Health / Monash University🌐Australia
Director of Hematology
90
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Constantine Tam led pivotal international trials of zanubrutinib including ASPEN in Waldenstrom macroglobulinemia and SEQUOIA in treatment naive CLL. His work established the efficacy and safety profile of second generation covalent BTK inhibitors. He is a recognized global authority in indolent B cell lymphomas.
Share:
🧪Research Fields 研究领域
zanubrutinib
CLL
Waldenstrom macroglobulinemia
BTK inhibitors
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Constantine Tam 的研究动态
Follow Constantine Tam's research updates
留下邮箱，当我们发布与 Constantine Tam（Alfred Health / Monash University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment